Epigral per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹62.82₹76.95₹84.68₹47.13₹85.03
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹62.82₹76.95₹84.68₹47.13₹85.03
₹514.94₹514.94₹441.48₹301.83₹257.30
₹608.72₹585.81₹591.13₹464.30₹526.69
—₹100.96₹102.12₹95.70₹150.70
₹9.59₹9.59₹56.99−₹0.19₹50.47
—₹4.25₹7.31₹2.50₹5.83
4.34.34.34.24.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

EPIGRAL₹907.30

Epigral Limited

· Chemicals
₹ CrorePeersYASHOGUJALKALIFCLFOSECOINDVISHNUTATVAGALAXYSURFJUBLCPLMcap ₹3,914 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS85.0347.1384.6876.9562.82
Diluted EPS85.0347.1384.6876.9562.82
Book Value per Share257.30301.83441.48514.94514.94
Revenue per Share526.69464.30591.13585.81608.72
Cash Flow per Share150.7095.70102.12100.96—
Free Cash Flow per Share50.47-0.1956.999.599.59
Dividends per Share5.832.507.314.25—
Shares Outstanding (cr)4.24.24.34.34.3
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.